tickerreport.com
Positivewww.tickerreport.com ·
oscar health nyseoscr rating increased to strong buy at wall street zen
EPU_CATS_ENTITLEMENT_PROGRAMSTAX_FNCACT_PEERTAX_FNCACT_EXECUTIVETAX_FNCACT_INSIDER
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article covers analyst upgrades and strong financial results for Oscar Health, a health insurance company. The commercial mechanism is limited to equity sentiment and insider buying, with no direct impact on product prices, supply chains, or scarcity. The primary affected sector is health insurance, but the mechanism is weak and stock-specific.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Oscar Health (NYSE:OSCR) upgraded to strong buy by Wall Street Zen on May 10, 2026.
- Barclays raised target price from $18.00 to $21.00.
- Quarterly EPS of $2.07 exceeded estimates.
- Revenue of $4.65 billion, up 52.6% year-over-year.
- CEO Mark T. Bertolini purchased 1,000,000 shares at $11.92 each.